Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Spillane

Showing results (181-190 of 223) with videos related to

Pageof 23
Sort By:
Annals of Surgical Oncology|August 4, 2021
Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for MelanomaAndrew T Li, Kavita Vakharia, Serigne N Lo, et al.
Journal of Translational Medicine|April 13, 2023
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approachYizhe Mao, Tuba N Gide, Nurudeen A Adegoke, et al.
Neurology|May 4, 2012
Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patientsM I Leite, E Coutinho, M Lana-Peixoto, et al.
Journal for Immunotherapy of Cancer|September 12, 2022
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sitesJordan W Conway, Robert V Rawson, Serigne Lo, et al.
Annals of Surgical Oncology|June 28, 2018
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
Annals of Surgical Oncology|June 1, 2018
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Journal of Translational Medicine|September 5, 2022
Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation settingMathias Seviiri, Richard A Scolyer, D Timothy Bishop, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2021
Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapiesSydney Ch'ng, Semra Uyulmaz, Matteo S Carlino, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 16, 2025
Longitudinal Analysis Reveals Dynamic Changes in Histopathologic Features in Responders to Neoadjuvant Treatment in a Stage III BRAF-Mutant Melanoma CohortJorja Braden, Alison Potter, Robert V Rawson, et al.
Pageof 23

Showing results (181-190 of 223) with videos related to

Sort By:
Pageof 23
Annals of Surgical Oncology|August 4, 2021
Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for MelanomaAndrew T Li, Kavita Vakharia, Serigne N Lo, et al.
Journal of Translational Medicine|April 13, 2023
Cross-platform comparison of immune signatures in immunotherapy-treated patients with advanced melanoma using a rank-based scoring approachYizhe Mao, Tuba N Gide, Nurudeen A Adegoke, et al.
Neurology|May 4, 2012
Myasthenia gravis and neuromyelitis optica spectrum disorder: a multicenter study of 16 patientsM I Leite, E Coutinho, M Lana-Peixoto, et al.
Journal for Immunotherapy of Cancer|September 12, 2022
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sitesJordan W Conway, Robert V Rawson, Serigne Lo, et al.
Annals of Surgical Oncology|June 28, 2018
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Annals of Surgical Oncology|May 18, 2024
The Effect of Neoadjuvant Systemic Therapy on Surgical Outcomes After Lymph Node Dissections for Stage III Melanoma; An Australian CohortLisanne P Zijlker, Henry Chen, Andrew J Spillane, et al.
Annals of Surgical Oncology|June 1, 2018
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Journal of Translational Medicine|September 5, 2022
Higher polygenic risk for melanoma is associated with improved survival in a high ultraviolet radiation settingMathias Seviiri, Richard A Scolyer, D Timothy Bishop, et al.
European Journal of Cancer (Oxford, England : 1990)|June 14, 2021
Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapiesSydney Ch'ng, Semra Uyulmaz, Matteo S Carlino, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 16, 2025
Longitudinal Analysis Reveals Dynamic Changes in Histopathologic Features in Responders to Neoadjuvant Treatment in a Stage III BRAF-Mutant Melanoma CohortJorja Braden, Alison Potter, Robert V Rawson, et al.
Pageof 23